Combination therapy of substituted oxazolidinones

Details Combination therapy of substituted oxazolidinones Combination therapy of substituted oxazolidinones

A - Human Necessities

61

K

A61K 31/4365 (2006.01) A61K 31/52 (2006.01) A61K 31/5377 (2006.01) A61K 31/60 (2006.01) A61P 7/02 (2006.01) A61P 9/04 (2006.01) A61P 9/10 (2006.01) A61P 43/00 (2006.01)

Patent

CA 2668068

The present invention relates to combinations of A) oxazolidinones of the formula (I) with B) acetylsalicylic acid (aspirin) and C) an ADP receptor antagonist, in particular P2Y12 purino receptor blocker, a process for producing these combinations and the use thereof as medicaments, in particular for the prophylaxis and/or treatment of thromboembolic disorders.

La présente invention concerne des combinaisons A) d'oxazolidinones de formule (I) avec B) de l'acide acétylsalicilique (aspirine) et C) un antagoniste du récepteur ADP, notamment un bloqueur du purinorécepteur P2Y12, un procédé de fabrication de ces combinaisons et leur utilisation en tant que médicament, notamment pour la prophylaxie et/ou le traitement de maladies thromboemboliques.

Affiliated with

Also associated with

Rating

Combination therapy of substituted oxazolidinones does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination therapy of substituted oxazolidinones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination therapy of substituted oxazolidinones will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2013346